1. Home
  2. IGMS vs FFIE Comparison

IGMS vs FFIE Comparison

Compare IGMS & FFIE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IGMS
  • FFIE
  • Stock Information
  • Founded
  • IGMS 1993
  • FFIE 2014
  • Country
  • IGMS United States
  • FFIE United States
  • Employees
  • IGMS N/A
  • FFIE N/A
  • Industry
  • IGMS Biotechnology: Pharmaceutical Preparations
  • FFIE Auto Manufacturing
  • Sector
  • IGMS Health Care
  • FFIE Consumer Discretionary
  • Exchange
  • IGMS Nasdaq
  • FFIE Nasdaq
  • Market Cap
  • IGMS 82.1M
  • FFIE 97.5M
  • IPO Year
  • IGMS 2019
  • FFIE N/A
  • Fundamental
  • Price
  • IGMS $1.38
  • FFIE $1.60
  • Analyst Decision
  • IGMS Hold
  • FFIE
  • Analyst Count
  • IGMS 8
  • FFIE 0
  • Target Price
  • IGMS $6.14
  • FFIE N/A
  • AVG Volume (30 Days)
  • IGMS 368.0K
  • FFIE 11.5M
  • Earning Date
  • IGMS 03-06-2025
  • FFIE 11-06-2024
  • Dividend Yield
  • IGMS N/A
  • FFIE N/A
  • EPS Growth
  • IGMS N/A
  • FFIE N/A
  • EPS
  • IGMS N/A
  • FFIE N/A
  • Revenue
  • IGMS $2,918,000.00
  • FFIE $537,000.00
  • Revenue This Year
  • IGMS $26.85
  • FFIE $10,958.67
  • Revenue Next Year
  • IGMS $125.17
  • FFIE $617.65
  • P/E Ratio
  • IGMS N/A
  • FFIE N/A
  • Revenue Growth
  • IGMS 57.64
  • FFIE N/A
  • 52 Week Low
  • IGMS $1.26
  • FFIE $0.99
  • 52 Week High
  • IGMS $22.50
  • FFIE $156.00
  • Technical
  • Relative Strength Index (RSI)
  • IGMS 26.21
  • FFIE 51.72
  • Support Level
  • IGMS $1.26
  • FFIE $1.49
  • Resistance Level
  • IGMS $1.54
  • FFIE $1.86
  • Average True Range (ATR)
  • IGMS 0.13
  • FFIE 0.18
  • MACD
  • IGMS 0.22
  • FFIE 0.04
  • Stochastic Oscillator
  • IGMS 29.27
  • FFIE 46.84

About IGMS IGM Biosciences Inc.

IGM Biosciences Inc is a biotechnology company engaged in the development of IgM antibody therapeutics for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. Its IgM antibody technology platform is suited for developing T cell engagers, receptor cross-linking agonists, and targeted cytokines. Its product candidate, Aplitabart: An IgM antibody targeting Death Receptor 5 (DR5) proteins, for the treatment of colorectal cancer; Imvotamab: A bispecific for severe systemic lupus erythematosus (SLE) and one for severe rheumatoid arthritis (RA); and IGM-2644: A bispecific T cell engaging IgM antibody targeting CD38 and CD3 proteins, currently planned for evaluation in autoimmune disease.

About FFIE Faraday Future Intelligent Electric Inc.

Faraday Future Intelligent Electric Inc is a global shared intelligent mobility ecosystem. It is poised to break the boundaries between the Internet, IT, creative, and auto industries with product and service offerings that integrate new energy, AI, Internet, and sharing models.

Share on Social Networks: